diethylnitrosamine has been researched along with Bone Cancer in 1 studies
Diethylnitrosamine: A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties.
N-nitrosodiethylamine : A nitrosamine that is N-ethylethanamine substituted by a nitroso group at the N-atom.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The second step is evaluation of the independent dose-response relationships observed in animals and prediction of human risk distributions by normalizing time units with respect to species natural life span." | 1.28 | Scaling of fatal cancer risks from laboratory animals to man. ( Raabe, OG, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raabe, OG | 1 |
1 other study available for diethylnitrosamine and Bone Cancer
| Article | Year |
|---|---|
Scaling of fatal cancer risks from laboratory animals to man.
Topics: Animals; Bone Neoplasms; Diethylnitrosamine; Dogs; Dose-Response Relationship, Drug; Dose-Response R | 1989 |